A Study of Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01).
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Eribulin-Based Regimen|DRUG: nab-paclitaxel based regimen|DRUG: Other Chemotherapy Regimen
Sponsor: Fujian Cancer Hospital